1. Home
  2. BNR vs CHMG Comparison

BNR vs CHMG Comparison

Compare BNR & CHMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$21.26

Market Cap

233.6M

Sector

Health Care

ML Signal

HOLD

Logo Chemung Financial Corp

CHMG

Chemung Financial Corp

HOLD

Current Price

$55.05

Market Cap

242.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNR
CHMG
Founded
2014
1833
Country
China
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
233.6M
242.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BNR
CHMG
Price
$21.26
$55.05
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$54.50
AVG Volume (30 Days)
66.8K
10.7K
Earning Date
11-20-2025
01-27-2026
Dividend Yield
N/A
2.47%
EPS Growth
N/A
N/A
EPS
N/A
2.80
Revenue
$75,749,382.00
$86,610,000.00
Revenue This Year
$136.32
N/A
Revenue Next Year
N/A
$32.65
P/E Ratio
N/A
$19.68
Revenue Growth
5.56
N/A
52 Week Low
$2.18
$40.71
52 Week High
$24.18
$60.80

Technical Indicators

Market Signals
Indicator
BNR
CHMG
Relative Strength Index (RSI) 56.39 48.87
Support Level $19.49 $53.83
Resistance Level $24.18 $60.80
Average True Range (ATR) 1.90 1.41
MACD 0.05 -0.27
Stochastic Oscillator 56.56 29.36

Price Performance

Historical Comparison
BNR
CHMG

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About CHMG Chemung Financial Corp

Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.

Share on Social Networks: